Skin Tears Treatment Market Analysis, Growth by Top Companies, Trends by Application, Forecast – 2028

Skin Tears Treatment: Market Insights

Skin tears have become a common issue among people of older age as the skin becomes more delicate and drier and so skin tears treatment has become an essential criteria for further spreading of infection. A skin tear is a form of sheer or tears away that occurs when skin becomes very thin and intricate. It is most often seen in old aged people as the blood vessels tend to be more atonic and feed fewer nutrients and moisture to the skin tissue. A skin tears treatment can be subcategorized into no skin loss, partial skin loss and total flap loss. According to one report published in NCBI, occurrence of incidence rates in skin tears is ranging between 2.23 % to 92 % in long duration care facilities and varies from 2.1% in men to 4.6% in women.

Skin Tears Treatment: Market Dynamics

Skin tears are acute wounds that are commonly found in elderly people and also in the neonate and pediatric population. Rising prevalence cases in skin tear are one of the most significant reasons responsible for the growth of the skin tears treatment market. According to 2018 ISTAP Consensus Statement, estimates of skin tear treatment prevalence in long-term care is 2.23%-92%, in the community it is 4.5%–19.5%, in acute care it is 6.2%–11.1%, in palliative care it is 3.3%-14.3% which indicates high growth in skin tears treatment market. Increasing aging population is another important factor in driving the skin tears treatment market. Factors such as increasing the length of hospitalization, rising cost in healthcare expenditure may become the restraining criteria for skin tears treatment market.

Request Report Sample@https://www.futuremarketinsights.com/reports/sample/rep-gb-8505

Skin Tears Treatment Market: Segmentation

The global skin tears treatment market is segmented by product type, factors and end user.

  • Segmentation by Product Type
    • Non-Adherent Mesh Dressings
    • Foam dressing
    • Hydrogels
    • 2-octyle cyanoacrylate topical bandage
    • Calcium Alginates
    • Hydrofibre
    • Acrylic Dressing
    • Methylene Blue and Gentian Violet Dressings
    • Ionic Silver Dressings
  • Segmentation by Factors
    • Intrinsic factors skin tears treatment
    • Extrinsic factors skin tears treatment
  • Segmentation by End User
    • Hospitals
    • Home care settings
    • Ambulatory Surgical Centers
    • Clinics
    • Others

Skin Tears Treatment Market: Overview

Skin tears are resulting in trauma to the skin from friction, shearing or blunt trauma. Due to physical changes related to co-existing illness and aging, skin tears treatment is becoming very difficult. Proper usage of adhesives and non-adhesive products, wound dressings is utmost essential in skin tears treatment. ConvaTec has launched Foam Lite dressing which is a silicone based adhesive foam dressings that are user-friendly, light and versatile to use for all skin tears treatment. Currently, silicone based adhesive foam dressing is leading the skin tears treatment market. With the advancement in technology in making more skin and user-friendly skin tears treatment products, the market is stimulating to have significant growth in the next few couples of years.

Skin Tears Treatment Market: Region-wise Outlook

On the basis of geography, the global versatile cryosurgical devices market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, and the Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America is projected to hold the largest share in the skin tears treatment market due to the occurrence of high incidence rate in skin tears and advanced healthcare facilities are having a high impact in overall skin tears treatment market. Europe holds the second position in skin tears treatment market due to increasing awareness among people about skin tears. For example, the European Wound Management Association has recently published modules on skin diseases educating people through the various campaign is driving the market for skin tears treatment. Asia Pacific, Middle East and Africa are also potentially stimulating the growth of the skin tears treatment market due to rising environmental factors, photoaging, chronological aging etc. are leading the skin tears treatment market. According to one report by International Wound Journal, almost 3.9% prevalence rate of skin tears was found in a long-term care facility in Japanese patients which indicates a gradual rise in skin tears treatment market.

Skin Tears Treatment Market: Key Players

Some of the key players present across the value chain of the global skin tears treatment market are Mölnlycke Health Care AB, Advancis Medical UK, ConvaTec Inc., KCI Licensing, Inc., 3M, AMERX Health Care, Coloplast Ltd., Gensco Pharma, McKesson Medical-Surgical Inc., Advanced Medical Solutions Group plc, Covalon Technologies Ltd., HARTMANN USA, Inc., Medline Industries, Inc, Hollister Incorporated.

For any queries linked with the report, ask an analyst@https://www.futuremarketinsights.com/ask-question/rep-gb-8505

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

Buy Report@https://www.futuremarketinsights.com/checkout/8505

Pressure Infusion Bags Market Is Expected To Grow At A CAGR Of ~6% During The Forecast Period Of 2019-2029

A new market research report by Future Market Insights on the pressure infusion bags market includes global industry analysis 2014 – 2018 and opportunity assessment 2019 – 2029. The report investigates the pressure infusion bags market and provides critical insights for the forecast period of 2019 -2029. As per the findings of the report, the global pressure infusion bags market is projected to experience significant growth over the forecast period due to multiple driving factors such as increasing emergency and transfusion cases and development of healthcare infrastructure across geographies.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-2243

The global pressure infusion bags market was valued at ~US$ 253 Mn in 2018, and is expected to increase at a CAGR of ~6% during the forecast period of 2019-2029. This growth is majorly driven by the increasing use of pressure infusion bags for rapid infusion of blood and drugs, in order to protect the end organ damage during traumatic conditions.

The overall progress of the healthcare sector and infrastructure in MEA and Asia-Pacific are likely to unfold lucrative opportunities for market players operating in the pressure infusion bags market. In addition, manufacturers are expected to primarily focus on developing cost-effective and user-friendly bags in the coming years. 

South Asia Continues to Hold Lucrative Opportunities

Regions such as North America and East Asia are expected to hold prominent market shares in terms of value. However, the South Asia market is expected to project lucrative growth in the global pressure infusion bags market over the forecast period of 2019-2029. This growth is propelled by the rapid growth and development of healthcare infrastructure, especially trauma care units, intensive care units and ambulatory surgical centers in countries of South Asia that include India and ASEAN countries. The economic condition of these countries have been developing positively, thereby creating newer growth opportunities for the market players.

Macroeconomic factors such as growing population, increasing immunosuppressed patient population, and increase in the number of players along with strong distribution network and rapid development in the healthcare infrastructure have attracted the attention of manufactures to establish a firm collaboration with local distributors in South Asia.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-2243

Hospitals and Outpatient Facilities Remain Key End Users for Pressure Infusion Bags

The global market of pressure infusion bags has been segmented on the basis of different types of pressure infusion bags products, their multiple applications, their volume capacity, their material, their targeted indications and regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East and Africa.

  • By type, the disposable type of pressure infusion bags segment is expected to hold prominent value shares of the global pressure infusion bags market. This has majorly resulted to avoid and minimizing chances of cross contamination during fluid infusion and ensures the patient safety
  • On the basis of application, the blood and drug infusion segment is expected to consume majority share of the global pressure infusion bags market value. Invasive Pressure monitoring procedures is the second application which account the remaining market share.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-2243

Pressure Infusion Bags Market: Vendor Insights

The report highlights some of the prominent market players, who have established themselves as leaders in the global pressure infusion bags market. Some of the examples of key players in the global pressure infusion bags market are VBM Medizintechnik GmbH, ERKA, Smiths Medical (Smiths Group plc.), Friedrich Bosch GmbH & Co. KG, Biegler GmbH, SARSTEDT AG & Co. KG. Vyaire Medical Inc., Spengler SAS, Armstrong Medical, SunMed and Statcorp Medical

Lung Cancer Surgery Market In-depth Analysis by Trends, Dynamics, Drivers, Challenges and Growth Factors by 2029

Over 2 million new cases of lung cancer were registered globally by the end of 2018, as reported by the American Cancer Society, Inc. The global lung cancer surgery landscape currently represents a US$ 1 Bn market and will expand at a strong CAGR during the period of projection, 2019 – 2029. A new Future Market Insights (FMI) report states that the use of techniques that are minimally invasive, video assisted, and robot assisted is growing, which is shaping the future of lung cancer surgery market.

Robotic thoracic surgery would remain highly preferred over traditional surgical techniques, as it offers higher magnification, more precision, and eliminate the need for large-incision operations. Development of new surgical robots may cut down the cost of devices and increase shift towards robotic lung cancer surgery. Introduction of new imaging techniques for enhancing visualization, angled lenses for enhanced accessibility, and end staplers will continue to enhance the video-assisted lung cancer surgery procedure.

Intuitive Surgical is the sole player in robotic lung cancer surgery market with its DaVinci system. Medtronic and Johnson & Johnson are developing surgical robots and are challenging the monopoly of Intuitive Surgical in lung cancer surgery market.

Key Takeaways – Lung Cancer Surgery Market Study

  • Introduction of powered and tissue-specific endoscopic stapling technology provides significant benefits to reduce cost, resource usage, improve clinical outcome compared to manual staplers.
    • In September 2019, Johnson & Johnson launched ECHELON CIRCULAR™ Powered Stapler for thoracic, colorectal, and gastric surgery.
    • In March 2016, Intuitive Surgical Inc. got U.S. FDA approval for its da Vinci Xi Endowrist Stapler 30 (30 mm) instruments and reloads.
  • Key market players are focusing on the development of new robot-assisted thoracic surgery system. Partnerships & collaborations with best in class surgical device and visualization technology developers are the strategic focus of manufacturers. For instance,
    • Medtronic partnered with Karl Stroz, a best in class endoscopic imaging devices manufacturer. In June 2019, Medtronic announced its upcoming robotic-assisted surgical platform including three-dimensional vision systems from Karl Stroz.
  • East Asia is expected to be the prominent region in the lung cancer surgery market during the forecast year. This is attributed to high prevalence of lung cancer in China & Japan increasing the demand for lung cancer surgery. According to the International Agency for Research on Cancer, from overall cancer patients in China and Japan, around 18.1% and 16.8% patients respectively were having lung cancer.

Development in robotic thoracic surgery platforms and innovation in tissue-specific endoscopic stapling and vessel sealing techniques to reduce endoleak complications will further broaden the growth prospects of the lung cancer surgery market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-396

Product Portfolio Expansion to Increase Global Footprint

Manufacturers are adopting product portfolio expansion strategy to increase their footprint in the global lung cancer surgery market. Market players such as Pentax Medical, Olympus, Johnson & Johnson, Intuitive Surgical Inc. are continuously focusing on new product launches and regulatory approvals. For instance,

  • In July 2016, PENTAX Medical launched new DEFINA high-definition pulmonology endoscopy system for crystal clear imaging during surgical procedures.
  • In April 2018, Intuitive Surgical Inc. received U.S. FDA clearance for da Vinci Vessel Sealer Extend single-use, the fully wristed bipolar electrosurgical instrument for lung cancer surgery procedures such lobectomy, segmentectomy, and wedge resection.

Key Segment

Product

  • Surgical Energy Instruments
    • Advanced Energy Instruments
      • Advanced Bipolar Instruments
      • Ultrasonic Instruments
    • Basic Energy Instruments
      • Bipolar Instrument
      • Monopolar Instruments
  • Thoracoscopes
  • Mediastinoscopes
  • Bronchoscopes
  • Robotic-Assisted Thoracic Surgery Systems
  • Surgical Staplers

Application

  • Lobectomy
  • Segmentectomy
  • Wedge Resection
  • Pneumonectomy

End User

  • Hospitals
  • Ambulatory Surgical Centers

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-396

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Tissue Engineered Skin Substitute Market is projected for a robust 9% CAGR during 2019 – 2029

Rapid expansion of wound management space has argued well for the growth in demand for tissue engineered skin substitutes. The global Tissue Engineered Skin Substitute Market is projected for a robust 9% CAGR during 2019 – 2029, predominantly driven by high applicability in diabetic foot ulcers and other chronic wounds.

With advent of tissue engineering and improved ability to combine advanced manufacturing technologies with biomaterials and cell culture systems, more biomimetic tissue constructs have been emerged. Technological advancements are leading to production of advanced tissue engineered skin substitutes. 3D bioprinting and biotextile are emerging as popular biofabrication strategies for creating bioengineered skin substitutes. A team of researchers in the U.S. recently discovered a technology for complete 3D printing of the living skin along with blood vessels. Emergence of such revolutionary fabrication technologies will create a massive opportunity in the global market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-781

Key Takeaways – Tissue Engineered Skin Substitute Market Study

• With increasing researches in tissue engineering, the demand for biologic skin substitute is expected to increase in the forecast period. For instance, a team of engineers at the California Institute of Technology (Caltech) and ETH Zurich have developed an artificial skin made from pectin, a naturally occurring long-chain molecule present in plant cell walls allowing the construction of natural and new dermis.
• Increasing prevalence of diabetes and chronic wounds is boosting the demand for tissue engineered skin substitutes.
• The demand for tissue engineered skin substitutes in emerging economies such as China and India is expected to increase owing to increasing incidence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

Leading Manufacturers Setting the Pace for Product Innovations
The tissue engineered skin substitute market is a consolidated market. The tier 1 companies in the tissue engineered skin substitute market such as Allergan Plc., Mimedex Group Inc., Integra LifeSciences Corp. and Integra LifeSciences Corp. are expected to hold more than half of the total revenue generated by tissue engineered skin substitutes. The key players in the market are reshaping their current product portfolio by focusing on the introduction of new and advanced technologies and innovating new products.

Get a Customized Scope to Match Your Need, Ask an Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-781

Seek More Insights

Tissue engineered skin substitute market, a new study from Future Market Insights, opines on the evolution of tissue engineered substitute market from 2014 – 2018 and presents demand projections from 2019 – 2029 on the basis of; product (acellular skin substitute, biologic skin substitute, cellular skin substitute and synthetic substitute), material (synthetic and natural), application (chronic wound, acute wound and other applications such as breast reconstruction etc.) and end user (hospital, specialty clinics, ambulatory surgical centres and research laboratories) across seven prominent regions.

Debashish Roy
Future Market Insights
+1 8455795705

Global Robotic Catheterization Systems Market Comprehensive Analysis, Opportunities and Forecast 2029

A recent clinical study radiation level research with robotic catheterization and normal cardiac intervention procedures reveals that robotic catheterization systems show reduction of ionizing radiation exposure by 95%. This factor will be prominent in pushing the preference for robotic catheterization systems as an effective procedure for catheterization. Projected to reach US$ 26 Mn by the end of 2019, robotic catheterization systems market is set to thrive at an impressive CAGR of 15% during the forecast period (2019 – 2029).

Interventional and surgical robotic systems have already made a significant impact on how surgeries are performed and are being increasingly adopted in modern operating rooms. Robotic catheterization systems have proved their abilities to perform interventional procedures with immensely low operator radiation exposure in comparison to the tradition catheterization procedures. Procedures where clinicians are given navigational and mechanical tools that permit definite actions or part of the procedure to be executed autonomously with a level of precession and control are possible only with robot-assisted catheterization.

Key Takeaways – Robotic Catheterization Systems Market Study

  • Popularity of robotic catheterization systems, increasing system awareness, improving reimbursement scenarios for percutaneous coronary intervention (PCI), larger patient pool for coronary artery diseases are key factors influencing the robotic catheterization systems market in developed countries.
  • High upfront cost is posing a negative impact on end users’ decision to purchase robotic catheterized systems. To rework this problem, Hansen Medical is offering sensei system at a competitive pricing depicting lower accessory cost and lower total cost per procedure.
  • Robotic catheterization systems installed in Chesapeake Regional Healthcare marks as the first fully integrated catheterization laboratory installed in its all intervention operating room.
  • In terms of product type, electromechanical robotic catheterization systems with comparatively higher technical advantage over magnetic-guided robotic catheterization systems is expected to generate significant revenue.
  • In terms of application, increasing adoption of robotic catheterization for percutaneous coronary intervention as compared to cardiac electrophysiology procedure marks higher revenue potential.

The first ever successful robotic PCI procedure in Asia Pacific that delivered positive results will be offering an inception point for the growth of robotic catheterization systems market in developing Asian economies.

Request Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9667

Market Leaders on Acquisition Spree

In reference to the trend in other medical device markets, key factors impacting the robotic catheterization systems market are partnerships and mergers observed in recent years. Key manufacturers are entering the robotic catheterization systems market by strategically expanding their reach through acquisitions and mergers, considering the increasing demand for these systems.

Product bundling of robotic catheterization and accessory systems at promotional rates and research contracts are forcing a decline in ASPs. Companies are focusing on limiting operational expenses to grow profitability. In contrast to these market changes, another significant factor influencing the robotic catheterization systems market is the exit and entrance of co-participating companies.

In August 2019, Corindus Vascular Robotics Inc., a prominent developer of precision vascular robotics, declared that it has settled on acquisition by Siemens Healthineers AG., representing a collective purchase price of approximately $1.1 billion. In April 2016, Hansen Medical Inc. was acquired by Auris Surgical Robotics Inc. in an arrangement with roughly US$ 80 Mn of equity value. With Hansen portfolio, Auris attained Magellan Robotic System, employed in navigating peripheral blood vessels in endovascular procedures, and Sensei Robotic System, a robotically steerable catheter system.

Robotic Catheterization Systems Market

Looking for More Insights?

Robotic catheterization systems market, a new study from Future Market Insights, provides unparalleled insights on evolution of the robotic catheterization systems market during 2014 – 2018 and presents demand projections during 2019 – 2029 on the basis of product category (Electromechanical robotic catheterization systems,  magnetic-guided robotic catheterization systems), application (percutaneous coronary intervention, cardiac electrophysiology procedures), and end user (hospitals, ambulatory surgical centers, catheterization laboratories) across seven prominent regions.

Any Queries, ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-9667

Table of Content

  1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

  1. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

  1. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Development Trends

  1. Market Context

4.1. Install Base Scenario

4.2. Reimbursement Scenario

4.3. Regulatory Scenario

4.4. Prevalence of Cardiac Disorders, By Country

  1. Global Robotic Catheterization Systems Market Demand Analysis 2014-2018  and Forecast, 2018-2028

5.1. Historical Market Volume (Units) Analysis, 2014-2018

5.2. Current and Future Market Volume (Units) Projections, 2018-2028

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

  1. Global Robotic Catheterization Systems Market – Pricing Analysis

6.1. Regional Pricing Analysis By Product Type

6.2. Pricing Break-up

6.2.1. Manufacturer Level Pricing

6.2.2. Distributor Level Pricing

6.3. Global Average Pricing Analysis Benchmark

Implantable Drug-Eluting Devices Market | Industry Report, 2021-2029

Implantable drug-eluting devices are playing a key role in the management and treatment of various chronic disorders, particularly cardiovascular diseases. Advancements in micro and nanotechnology are aiding key manufacturers to design novel implantable drug-eluting devices.

Moreover, controlled and site-specific attributes of implantable drug-eluting devices, further complemented by compatibility with the targeted drug delivery, are relieving the burden of complex dosing schedule and systemic toxicity of conventional drug delivery system. The global implantable drug-eluting devices market is projected to cross the US$ 10 Bn mark towards the end of 2019. Market leaders in implantable drug-eluting devices landscape are maintaining their focus on refining manufacturing processes.

Remote-Controlled Chips and Programmable Devices – Future of Targeted Drug Delivery

Increasing clinical trials and research & development of remote-controlled and programmable drug-eluting devices

Massachusetts Institute of Technology (MIT) researchers have developed a remote-controlled contraceptive hormone (levonorgestrel) delivery chip implant, which can turn the device on and off.

Implantable drug-eluting devices allow minimum effective doses and support oral opioid weaning

Implantable drug-eluting devices such as SynchroMed II intrathecal drug delivery system with controlled workflow system, plays an effective role in reducing or eliminate the use of oral opioids.

Antiretroviral (ARV) drug implant is expected to emerge as a promising approach for HIV treatment and prevention

In July 2019, Merck & Co. started the development of slow-release antiretroviral (ARV) drug implant as a promising approach for HIV treatment.

Growth of implantable drug-eluting devices market can be prominently attributed to the associated cost-effective technology and novel medication administration techniques. Fewer side effects while these devices are utilized in the management of chronic diseases as well as in contraception have been the strongest attribute accounting for a steadily expanding market for implantable drug-eluting devices.

Request Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-10671

Medical-Pharma Collaborating to Balance Demand and Supply

A comprehensive view of the implantable drug-eluting devices market has led our analysts to conclude that, the market is expected to grow with an impressive rate. This market growth is mainly attributed due to increasing innovations and developments in implantable drug-eluting devices for the management and treatment of breast cancer, schizophrenia, Parkinson’s disease, and photosensitivity diseases. Besides, FMI analyst suggests that markets in North America and Europe are expected to hold major value shares in global implantable drug-eluting devices landscape. To cater to rising demand for implantable drug-eluting devices, medical device companies are collaborating with pharmaceutical companies for the development of efficient drug delivery devices.

Increasing use of syringe-based subcutaneous implantable drug-eluting devices is anticipated to minimize the number of invasive surgical procedures. Introduction of implantable drug-eluting devices or rare conditions such as central precocious puberty (CPP) will emerge as an important factor shaping the market for implantable drug-eluting devices.

Know More About Implantable Drug-Eluting Devices Market Report

The implantable drug-eluting devices market, a new study from Future Market Insights, opines on the evolution of the implantable drug-eluting devices market from 2014 – 2018 and presents demand projections from 2019 – 2029 on basis of product type (implantable drug infusion pumps, intraocular drug-eluting devices, contraceptive drug-eluting devices, buprenorphine implant and drug-eluting stents), technology (active drug-eluting devices and passive drug-eluting devices) applications (diabetes macular edema, birth control/contraception, opioid addiction, cardiovascular, ophthalmology, oncology, pain management, others) implantation type (intravaginal, intravascular, intraocular, intrathecal, subcutaneous, intrauterine) end users (hospitals, ambulatory surgical centers, optical care centers, cardiac surgery centers, office-based setting and others) in seven prominent regions.

Any Queries, ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-10671

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Global Organoids Market Is Estimated To Reachus$ 44.2 Mn In 2021

Organoids are three-dimensional (3D) structures that resemble mammalian organs and are made from stem cells. As per a study by Future Market Insights (FMI), the global organoids market is estimated to reachUS$ 44.2 Mn in 2021.

As new platforms for quicker drug development and improved model structures for assessing drug efficacy and toxicity, organoids have the potential to be transformative.Traditional drug discovery approaches are less important and inadequate to keep up with the rapid pace of life science advancements. Organoids are projected to exhibit increasing sales within the drug discovery industry.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-8106

The demand for cutting-edge preclinical testing methods has increased as a result of advances in drug therapies such as personalized treatments and expanding medical research to identify new advance medicines.Organoids also are used to shortlist possible drug molecules and remove the remainder by considering ‘in-vitro’ conditions that are somewhat close to natural environmental conditions.

According to the International Federation of Pharmaceutical Manufacturers and Societies, preclinical research accounts for about 22% of the overall cost of drug production. The use of organoids in drug development shortens the process and saves money, resulting in a greater demand for organoids.

In terms of product, intestinal organoids are expected to register high demand, accounting for over 36% of sales in the market. While application of organoids is expected to be considerably high in bio banking.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-8106

Key Takeaways from Organoids Market Study

  • The organoids market will exhibit solid growth, registering above 14% CAGR between 2021 and 2031
  • The expansion of pharmaceutical sector and investment in research initiatives will enable the U.S. account for over 95% sales in North America
  • The U.K. will emerge as the leading market, exhibiting above 20% y-o-y growth in 2021
  • Germany and France are expected to emerge as other lucrative markets within the U.K.
  • China will remain a leading market for organoids in East Asia, however, the Japan market will register a slightly higher rate of growth

“Capability of 3D-organoid cultures to mimic organ functionality as well as increasing adoption of the organoid technology for use in a range of applications, including genetic mutation and other is expected to drive the growth of Organoids market” says the FMI Analyst

Funding for life science research and investments in Organoids products to expand various projects and personnel employedis the major factor expected to boost the organoids market growth.

For instance, the total amount of research grants awarded by the National Institutes of Health (NIH) in the U.S. exceeded US$ $251 million over five years (2015 to 2019).

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-8106

Key players in the Organoids are Entering into Strategic Alliance

The top players are focusing on expanding their business footprint through acquisitions. Acquisitions provide the company with strong foot hold of new products, buyer suppliers relationship, and new geographic horizons to tap the market potential. The key manufacturers aretargeting towardsacquiring well-known products and technologies that are expected to have a successful revenue stream. This also helps the business to grow into new emerging markets while also developing existing ones.

For instance, in September 2020,a Memorandum of Understanding (MoU) was signed by BGI-Qingdao and Ubrecht Organoid Technology (HUB) to develop a joint Next Generation Diagnostics (NGD) centre in China to improve personalised care, better treatments and cures, and faster development of new safe medicines.HUB and BGI will combine their complementary skills and technologies to further improve and incorporate HUB Organoid Technology as predictive diagnostic tests, allowing for reliable patient-specific treatment response prediction, initially with a focus on cancer.

As a result of increased emphasis on oncological research and increased R&D spending, the global organoids market is expected to expand over the forecast period. Organoids market is highly competitive exhibiting the presence of several players. Because of the high capital investment required to build an Organoids manufacturing facility, pharmaceutical companies are increasingly looking to outsource the process.The key market players covered by FMI include STEMCELL Technologies Inc., Cellesce Ltd., DefiniGEN, Qgel, Hubrecht Organoid Technology, OcellO B.V.consolidating their positions through mergers, acquisitions and new product launches.

Oscillating Positive Expiratory Pressure Devices Market is anticipated to grow at a CAGR of ~5% during 2019 to 2029 – Future Market Insights

A new market research report by Future Market Insights (FMI) on the oscillating positive expiratory pressure (OPEP) devices market includes global industry analysis 2014–2018 and opportunity assessment 2019–20289. According to report findings, the global oscillating positive expiratory pressure devices market was valued ~US$ 100.0 Mn in 2018, and is expected to increase at a CAGR of ~5% during the forecast period of 2019 and 2029.

The study opines that the global OPEP devices market is projected to witness significant growth over the forecast period due to multiple driving factors such as increasing regional availability of the oscillating positive expiratory pressure devices. The promising growth prospects are attributed to the innovative approach followed by manufacturers in designing devices, and the increasing adoption of OPEP devices among patients with respiratory diseases.

Download the sample copy of Report with table of contents and Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3397

Regions such as North America and Europe are expected to hold a prominent market share in terms of value. However, the East Asia market is expected to project lucrative growth in the global oscillating positive expiratory pressure devices market in the forecast period of 2019-2029. This growth is majorly propelled by increasing regional manufacturers resulting in increased product availability at affordable costs.

Furthermore, prevalence of chronic obstructive pulmonary diseases (COPD) is on the rise due to increasing smoking population in China and aging population in Japan with respiratory disorders. Although, low awareness about oscillating positive expiratory pressure devices among healthcare professionals and patients is hampering the potential growth of the oscillating positive expiratory pressure devices market.

Preview Analysis of Oscillating Positive Expiratory Pressure (OPEP) Devices Market is segmented by (Product Type – Facemask OPEP Devices, Mouthpiece OPEP Devices & Bottle OPEP Devices; Indication – COPD, Asthma, Atelectasis, Bronchitis, Bronchiectasis, Cystic Fibrosis & Others; Distribution Channel – Hospital Pharmacies, Retail Pharmacies & Online Pharmacies/ Online Sales) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 – 2029: https://www.futuremarketinsights.com/reports/oscillating-positive-expiratory-pressure-opep-devices-market

Mouthpiece OPEP Devices – Preferred Choice for Airway Clearance

Based on the analysis of OPEP devices market by product, mouthpiece oscillating positive expiratory pressure devices are expected to hold a prominent value share in the global market. This, according to FMI’s analysis, has majorly resulted from the ease of use of these devices as well as comparatively wider availability in the market.

On the other side, based on indication, the COPD is likely to consume a majority share of the oscillating positive expiratory pressure devices market value. This is majorly due to the higher prevalence of the disease and adoption of oscillating positive expiratory pressure devices for disease management. Although, cystic fibrosis is rare disease and has limited patient pool yet adoption of oscillating positive expiratory pressure devices remains highest in cystic fibrosis patients.

Buy this report @ https://www.futuremarketinsights.com/checkout/3397

OPEP Devices Market: Vendor Insights

The report highlights some of the prominent market players, who have established themselves as leaders in the global oscillating positive expiratory pressure devices market. Some of the prominent key players in the global OPEP devices market are Smiths Medical Inc., Allergan plc, PARI GmbH, Monaghan Medical Corporation, Trudell Medical International, Actegy Health Ltd., WyMedical Pty Ltd, R. Cegla GmbH & Co. KG, etc.

The global oscillating positive expiratory pressure devices market is significantly consolidated, with top two players holding prominent shares in the market revenues. These players are offering oscillating positive expiratory pressure devices under their popular brands such as Portex®, Flutter®, and Aerobika®, among others.

For additional insights on the oscillating positive expiratory pressure devices landscape, write to the analyst at press@futuremarketinsights.com

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with youhttps://www.futuremarketinsights.com/askus/rep-gb-3397

Stool Management Systems Market is expected to reach US$ 242.4 Million, growing at a CAGR of 3.8 % for 2021-2031

According to Future Market Insights (FMI), the demand for stool management systems is expected to rise significantly, reaching a market value of USD$ 166.5 Mn by the end of 2021.

Stool management systems are designed for bed ridden patients with fecal incontinence, a condition commonly known as bowel incontinence. These systems are used to prevent infections and reduce nursing time requirements.

The stool management systems are advantageous for older adults and patients suffering from constipation and fecal incontinence. Furthermore, it is also helpful for bed-ridden patients who may have been subject to aliments such as strokes, paralysis, or spinal injury.

According to the World Bank, approximately 700 million people were aged 65 and above in the world in 2019. Consequently, the overall high incidence of geriatric populations is resulting in the expansion of the patient pool and the resultant increase in the demand for stool management systems globally.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-3568

Fecal incontinence issues are common around the world and it has a notable burden on the economy and healthcare systems of society. The condition has impacted the economic system including hospital charges and nursing charges. Stool management systems help in reducing the nursing time and other hospital expenses.

Key players are focusing on strengthening their mergers and acquisition portfolios, in addition to advancement in technologies and new product launches. Europe holds the highest share in the market due to a vast target demographic, the presence of major market players, and high healthcare expenditure in the region.

Key Takeaways from Stool Management Systems Market Study

  • Systems are key to revenue generation in the stool management systems market surpassing accessories. They are likely to account for 63% value share by the end of the forecast period.
  • Luer-lock syringes will lead, with a valuation of over US$ 16 Bn by the end of 2021 owing to security in drug administration processes.
  • The U.S. accounts for more than 92% share in the North America market, and will witness growth backed by presence of a well-established healthcare sector.
  • Germany and France are leading countries in Europe and will account for more than 18% and 16% of the Europe market respectively in 2021.
  • Australia is the largest and fastest growing market in Oceania, exhibiting 6.2% CAGR during the forecast period.

The global stool management systems market is set to expand due to the rising number of people suffering from stool related ailments. Leading organizations within the market are set to focus on research for healthcare systems to offer increasingly effective treatment options for superior patient outcomes.

Some of the leading players in the stool management systems market include B. Braun Melsungen AG, Becton Dickinson, ConvaTec, Inc., Hollister Incorporated, Prosyn International Ltd., Consure Medical and others.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-3568

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Pedicle Screw Systems Market to Grow at a CAGR of 5.0% through 2029 | Future Market Insights

Global Pedicle Screw Systems Market 

The Global Pedicle Screw Systems Market registered revenues a value of US$ XX Bn in 2018, The Pedicle Screw Systems Market is expected to grow at healthy CAGR of XX% over the foreseeable timeframe 2019-2029. In this research study, 2019 is considered as the base year.

The Pedicle Screw Systems Market study presents a compilation of market share, demand analysis, and future outlook associated with each segment as well as sub-segment. The key segments include- By Product, By Material, By Application, By Level of Surgery, By End User and By Region Important Based on Product -wise segments covered contain Cervical Pedicle Screw Systems, Thoraco-Lumbar Pedicle Screw Systems. The Pedicle Screw Systems Market based on Level of Surgery- One-level Pedicle Screw Systems,  Two-level Pedicle Screw Systems, Three-level Pedicle Screw Systems, Four-level and higher Pedicle Screw Systems.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3970 

Limited tie offer for new entrants!!! Buy reports at discounted prices!!! 

The Pedicle Screw Systems Market report highlights the following stakeholders (At least 5):

  • Medtronic plc
  • DePuy Synthes Inc
  •  Zimmer Biomet Inc
  • Stryker Corp
  • Orthofix Inc
  • NuVasive Inc.

By Region -wise Segmentation Assessment:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Download Methodology of this Report @ https://www.futuremarketinsights.com/askus/rep-gb-3970 

The Pedicle Screw Systems Market research covers an exhaustive analysis of the following data:

  • Synopsis of recent R&D activities implemented by each Pedicle Screw Systems Market player.
  • Segmentation of the Pedicle Screw Systems Market to highlight the growth prospects and trends impacting these segments.
  • Factors (Positive and Negative) affecting the growth of the global Pedicle Screw Systems Market.
  • Comprehensive analysis of the impacts of the growth of relevant industries.
  • Exhaustive understanding of the strengths, weaknesses, opportunities and threats of various Pedicle Screw Systems Market players.

Get Full Access of the Press-Release Report @ https://www.futuremarketinsights.com/press-release/pedicle-screw-systems-market 

The Pedicle Screw Systems Market research answers the following questions: 

  1. Which country in region is expected to hold the largest share by 2014?
  2. How are the players overcoming the challenges associated with the Pedicle Screw Systems Market?
  3. What modifications are the Pedicle Screw Systems Market players performing to receive regulatory approvals in specific regions?
  4. What are the underlying micro- macroeconomic factors impacting the global Pedicle Screw Systems Market?
  5. What is future prospect of Pedicle Screw Systems Market in end use segment?

Get Full Access of the Report @ https://www.futuremarketinsights.com/reports/pedicle-screw-systems-market 

A thorough primary and secondary research has been performed to extract the nuts and bolts of the Pedicle Screw Systems Market. Various service providers, implementation vendors and research in different departments of all gamut of companies were approached to provide a clear-cut picture of the market structure. Further, DROT analysis and Porter’s Five Forces analysis are used to offer the factors (positive and negative) impacting the growth of the Pedicle Screw Systems Market.